<sentence id="0">A rapid PCR method for genotyping the Large(myd) mouse , a model of glycosylation-deficient congenital muscular dystrophy .</sentence>
<sentence id="1">The myodystrophy ( Large(myd) ) mouse has a spontaneous loss of function mutation in a <scope type="spec" id="0"> <cue type="spec" id="0">putative</cue> glycosyltransferase gene ( Large</scope> ) .</sentence>
<sentence id="2">Mutations in the human gene ( LARGE ) have been described in congenital muscular dystrophy type 1D ( MDC1D ) .</sentence>
<sentence id="3">Mutations in four other genes that encode known or <scope type="spec" id="1"> <cue type="spec" id="1">putative</cue> glycosylation enzymes ( POMT1 , POMGnT1 , fukutin and FKRP</scope> ) are also associated with muscular dystrophy .</sentence>
<sentence id="4">In all these diseases hypoglycosylation of alpha-dystroglycan , and consequent loss of ligand binding , is a common pathomechanism .</sentence>
<sentence id="5">Currently , the Large(myd) mouse is the principal animal model for studying the underlying molecular mechanisms of this group of disorders .</sentence>
<sentence id="6">Over-expression of LARGE in cells from patients with mutations in POMT1 or POMGnT1 results in hyperglycosylation of alpha-dystroglycan and restoration of laminin binding .</sentence>
<sentence id="7">Thus , LARGE is a potential therapeutic target .</sentence>
<sentence id="8">Here , we define the intronic deletion breakpoints of the Large(myd) mutation and describe a simple , PCR-based diagnostic assay , facilitating the study of this important animal model .</sentence>